A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Clinical trial NCT06616194 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06616194
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2028-08-19
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.